Massive study tracks liver transplant patients and donors for years
NCT ID NCT07301853
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows thousands of liver transplant recipients and living donors over many years. Researchers collect health data to find out what leads to complications and how to improve care. The goal is to create better follow-up plans and improve quality of life for both groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 9,999 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Dec 2045
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population comprises all consecutive patients with end-stage liver disease or acute liver failure scheduled for liver transplantation (recipients) and healthy individuals undergoing living donor hepatectomy (donors) at the Department of Liver Surgery of the study center. Participants are selected from the clinical practice setting of the study center.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients undergoing liver transplantation or living donor hepatectomy at the study center (living donor should be approved by the hospital ethics committee for living organ donation); 2. Age 18 years or older; 3. Willing to participate in the long-term follow-up management program; 4. Signed informed consent form; Exclusion Criteria: 1. Patients undergoing combined organ transplantation 2. Patients with severe mental illness or cognitive impairment who are unable to cooperate with follow-up assessments. 3. Donors whose surgery is aborted intraoperatively for any reason. 4. Unable or unwilling to comply with the long-term follow-up schedule.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Deceased donor liver transplantation recipients are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
The Second Affiliated Hospital Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310009, China